Scholars Central

Conference abstractPublished 15 Jul 2013

98.7 % survivability and 100% resolution of cholestasis among the patients with short bowel syndrome (SBS), treated with medical and non- transplant surgical options at the Intestinal Rehabilitation Program (IRP) at Chil

Authors: Clarivet Torres

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We reviewed the outcomes of 78 patients with SBS treated at the IRP over 5 years. Seventy-eight SBS-PN dependent patients were enrolled with a median age of 5 months and a median intestinal length of 40cm; thirty were female. The initial median daily caloric requirements by PN were 100%. Forty-eight have hyperbilirubinemia (mean DB of 10 mg/dl). Twenty had liver biopsies (twelve portal-fibrosis, five bridging-fibrosis, three cirrhosis). Height, weight Z score, platelet, albumin, bilirubin were obtained at the beginning and end of the study. Forty-eight had hyperbilirubinemia that normalized over a mean time of 10.4 weeks using soy-bean-intralipid (SBIL). Thirtynine reversed their cholestasis while receiving PN (81%). Twenty-five patients had 28 lengthening procedures (9-Bianchi/19 STEP); nine had ostomy in continuity. Four were listed for intestinal transplant; among them, two were transplanted, one was weaned off PN, and the other is inactive with normal bilirubin. One died (cardiac anomalies). Of the seventy-five remaining patients, 60 (80%) were weaned off PN. All laboratory parameters showed improvement (p< 0.0001). Overall survival was 98.7% SBS patients treated at CNMC reversed their cholestasis with the use of SBIL in a shorter time, compared with reports using Omegaven. With medical/surgical management, SBS-patients with advanced liver disease can improve their liver functions and nutritional parameters with the ability to discontinue PN and avoid transplantation. The treatment of SBS PN-dependent patients should be based on medical and non-transplant surgical options. Intestinal transplant should be considered when those measures fail. Our IRP has demonstrated 98.7% of survivability among SBS-patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nutrition & Food Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nutrition & Food Sciences
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Clarivet Torres”